Since, as parkin often co-localizes with ASN inclusions in PD patient’s brain tissue [3, 26], and many posttranslational modifications of parkin are associated with the toxic conditions evoked by ASN, it is proposed that ASN may affect parkin catalytic activity, solubility, substrate selection, and subcellular localization. This evidence concerns the gene PRKN and Parkinson disease.